San Francisco, CA – According to filings with the U.S. Securities and Exchange Commission, OneSkin is raising $12,412,714.00 in new funding. Sources indicate as part of senior management President, Carolina deOliveira played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About OneSkin
OneSkin is a longevity company on a mission to transform the way we think about skin and aging. Founded by a team of four female PhDs, OneSkins products aim to extend skinspan, the period of time skin is healthy and functional. OneSkins proprietary peptide, OS-01, is the first ingredient designed to reduce skins biological age by improving skin barrier, supporting DNA damage repair, and preventing the accumulation of aged cells.

To learn more about OneSkin, visit http://www.oneskin.co/

Contact:
Carolina deOliveira, President
415-910-8517
https://www.linkedin.com/in/carolina-reis-oliveira-a69b8a27/

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved